Parvathareddy, S.K.; Siraj, A.K.; Annaiyappanaidu, P.; Ahmed, S.O.; Al-Sobhi, S.S.; Al-Dayel, F.; Al-Kuraya, K.S.
Recurrent Middle Eastern Differentiated Thyroid Carcinoma Has Worse Outcomes Than Persistent Disease. J. Clin. Med. 2024, 13, 1877.
https://doi.org/10.3390/jcm13071877
AMA Style
Parvathareddy SK, Siraj AK, Annaiyappanaidu P, Ahmed SO, Al-Sobhi SS, Al-Dayel F, Al-Kuraya KS.
Recurrent Middle Eastern Differentiated Thyroid Carcinoma Has Worse Outcomes Than Persistent Disease. Journal of Clinical Medicine. 2024; 13(7):1877.
https://doi.org/10.3390/jcm13071877
Chicago/Turabian Style
Parvathareddy, Sandeep Kumar, Abdul K. Siraj, Padmanaban Annaiyappanaidu, Saeeda O. Ahmed, Saif S. Al-Sobhi, Fouad Al-Dayel, and Khawla S. Al-Kuraya.
2024. "Recurrent Middle Eastern Differentiated Thyroid Carcinoma Has Worse Outcomes Than Persistent Disease" Journal of Clinical Medicine 13, no. 7: 1877.
https://doi.org/10.3390/jcm13071877
APA Style
Parvathareddy, S. K., Siraj, A. K., Annaiyappanaidu, P., Ahmed, S. O., Al-Sobhi, S. S., Al-Dayel, F., & Al-Kuraya, K. S.
(2024). Recurrent Middle Eastern Differentiated Thyroid Carcinoma Has Worse Outcomes Than Persistent Disease. Journal of Clinical Medicine, 13(7), 1877.
https://doi.org/10.3390/jcm13071877
